Research Article
Identifying High-Cost, High-Risk Patients Using Administrative Databases in Tuscany, Italy
Table 3
Characteristics and outcomes in 2015 for complex patients disaggregated by TP, FN, and FP.
| True positive | False negative | False positive | Age group | Number | Percentage | Age group | Number | Percentage | Age group | Number | Percentage |
| 60–74 | 251 | 31 | 60–74 | 63 | 21 | 60–74 | 181 | 41 | 75–79 | 162 | 20 | 75–79 | 50 | 17 | 75–79 | 108 | 24 | 80+ | 395 | 49 | 80+ | 189 | 63 | 80+ | 157 | 35 |
| Total | 808 | 100 | Total | 302 | 100 | Total | 446 | 100 |
| Gender | Number | Percentage | Gender | Number | Percentage | Gender | Number | Percentage |
| Male | 389 | 48 | Male | 133 | 44 | Male | 216 | 48 | Female | 419 | 52 | Female | 169 | 56 | Female | 230 | 52 |
| Total | 808 | 100 | Total | 302 | 100 | Total | 446 | 100 |
| Number and prevalence (%) considering MaCro | Number and prevalence (%) considering MaCro | Number and prevalence (%) considering MaCro | Chronic diseases | Number | Percentage | Chronic diseases | Number | Percentage | Chronic diseases | Number | Percentage |
| Heart failure | 170 | 21 | Heart failure | 48 | 16 | Heart failure | 47 | 11 | Ischaemic cardiopathy | 284 | 35 | Ischaemic cardiopathy | 80 | 26 | Ischaemic cardiopathy | 107 | 24 | COPD | 282 | 35 | COPD | 64 | 21 | COPD | 145 | 33 | Dementia | 110 | 14 | Dementia | 16 | 5 | Dementia | 34 | 8 | Diabetes | 211 | 26 | Diabetes | 78 | 26 | Diabetes | 147 | 33 | At least one chronic disease | 713 | 88 | At least one chronic disease | 174 | 58 | At least one chronic disease | 368 | 83 |
| Number and prevalence (%) considering hospitalisation database | Number and prevalence (%) considering hospitalisation database | Number and prevalence (%) considering hospitalisation database | ACC | Number | Percentage | ACC | Number | Percentage | ACC | Number | Percentage |
| Card 1 | 74 | 9 | Card 1 | 29 | 10 | Card 1 | 13 | 3 | Card 2 | 187 | 23 | Card 2 | 66 | 22 | Card 2 | 81 | 18 | Card3 | 10 | 1 | Card3 | 6 | 2 | Card3 | 0 | 0 | CerVa1 | 49 | 6 | CerVa1 | 31 | 10 | CerVa1 | 19 | 4 | CerVa2 | 7 | 1 | CerVa2 | 2 | 1 | CerVa2 | 2 | 0 | GI | 8 | 1 | GI | 7 | 2 | GI | 5 | 1 | Canc | 30 | 4 | Canc | 27 | 9 | Canc | 16 | 4 | Kidn | 13 | 1 | Kidn | 5 | 2 | Kidn | 7 | 2 | Neur | 401 | 50 | Neur | 27 | 9 | Neur | 3 | 1 | Resp | 116 | 14 | Resp | 37 | 12 | Resp | 30 | 7 | At least one | 401 | 50 | At least one | 153 | 51 | At least one | 159 | 36 |
| Average number of diseases | 1.1 | | Average number of diseases | 0.7 | | Average number of diseases | 0.4 | |
| Consumptions | Number | Percentage | Consumptions | Number | Percentage | Consumptions | Number | Percentage |
| Hospital admissions | 101 | 13 | Hospital admissions | 1 | 0 | Hospital admissions | 30 | 7 | Average number of hospitalisations | 399/808 = 4.5 | Average number of hospitalisations | 51/302 = 0.16 | Average number of hospitalisations | 139/446 = 0.31 | ER admissions | 205 | 25 | ER admissions | 13 | 4 | ER admissions | 98 | 22 | Examinations | 198 | 25 | Examinations | 16 | 5 | Examinations | 109 | 24 | Laboratory tests | 320 | 40 | Laboratory tests | 21 | 7 | Laboratory tests | 214 | 48 | ATC | 309 | 38 | ATC | 13 | 4 | ATC | 67 | 15 | UVM/ADP | 163 | 20 | UVM/ADP | 10 | 3 | UVM/ADP | 70 | 16 |
|
|